Clinical trials: Doxycycline
Dry Eye
A Study of ALTY-0501 for the Treatment of Dry Eye Administered 4 Times a Day for a 56 Day Period
The objective of this study is to assess the safety and efficacy of doxycycline 0.025% (ALTY-0501) ophthalmic solution for the treatment of dry eye using the Controlled Adverse Environment (CAE) Model.
- Trial name
- NCT00439400
- Testing
- doxycycline
- Where
- United States
- Volunteers
- 160 people
- Sponsor
- Alacrity Biosciences, Inc.
Oral Lichen Planus
Study of Metronidazole and Doxycycline to Treat Oral Lichen Planus and to Compare Their Efficacy With Each Other
Oral lichen planus (OLP) is a chronic inflammatory disorder which causes local irritation,discomfort and subsequent poor dentition and discomfort in eating .
- Trial name
- NCT00484250
- Testing
- metronidazole,doxycycline
- Where
- Iran
- Volunteers
- 20 people
- Sponsor
- Mashhad University of Medical Sciences
Infection
Trimethoprim-Sulfamethoxazole or Doxycycline for Skin and Soft Tissue Infections
Background: In many communities, skin and soft tissue infections (SSTI) with MRSA have become more prevalent than infections with β-lactam susceptible bacteria.
- Trial name
- NCT00428818
- Testing
- trimethoprim-sulfamethoxazole or doxycycline
- Volunteers
- 75 people
- Sponsor
- University of Texas Southwestern Medical Center
Mycoplasma Pneumoniae
Randomized Controlled Trial of Doxycycline to Prevent Acquisition of Mycoplasma Pneumoniae in an Outbreak Setting
This study was designed to determine whether taking daily doxycycline during an outbreak of Mycoplasma pneumoniae could prevent a person from getting infected and interrupt ongoing disease transmission during an outbreak.
- Trial name
- NCT00207584
- Testing
- Doxycycline treatment
- Volunteers
- healthy volunteers welcome
- Sponsor
- Centers for Disease Control and Prevention
Rosacea
A Clinical Trial to Determine the Effects of 40 Mg Doxycycline Versus a Placebo Control for the Treatment of Rosacea
The objective of this study is to evaluate the safety and efficacy of 40 mg doxycycline controlled-release capsules administered once daily for the treatment of rosacea compared with a placebo.
- Trial name
- NCT00126399
- Testing
- doxycycline
- Volunteers
- 528 people
- Sponsor
- CollaGenex Pharmaceuticals
Acne Rosacea
Determine the Effect of Administering Periostat(R) Twice Daily on Patients With Acne Rosacea
The purpose of this study is to determine whether Periostat(R), Doxycycline Hyclate 20 mg Tablets, taken twice daily is effective in reducing the red and white heads and overall redness associated with rosacea.
- Trial name
- NCT00041977
- Testing
- doxycycline hyclate 20 mg twice daily
- Where
- 7 sites in United States
- Volunteers
- 150 people, healthy volunteers welcome
- Sponsor
- CollaGenex Pharmaceuticals
Endometrial Bleeding, Periodontal Disease
Norplant and Irregular Bleeding/Spotting
Irregular or prolonged menstrual bleeding and/or spotting are common side effects in patients using progestin-only hormonal contraception such as levonorgestrel implants (Norplant).
- Trial name
- NCT00064766
- Testing
- doxycycline
- Where
- United States
- Volunteers
- 50 people, healthy volunteers welcome
- Sponsor
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)